Leveraging over a decade of cutting-edge research, Prism AI is tackling a major challenge in precision medicine: building an end-to-end AI-first Multi-Omics data management and analytics platform for drug development and biomarker discovery. Prism’s technology is uniquely capable of detecting novel molecular and mechanistic signals in multi-dimensional data with millions of features and a small number of patients. We are working with our customers, including Biotech companies, Foundations and Health Systems, to unlock the value of their own data and create the next generation of drugs and biomarkers.